Delivery Order SPE2DR25D1106-SPE2DR26FJE6B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $45,979.62 to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,039.26 to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count packaging) on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Everolimus is a pharmaceutical product used in immunosuppression and cancer...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count) under a firm fixed-price contract valued at $5,473.37, with an ultimate completion date of November 21, 2025. This non-set-aside award was competitively procured and represents a single delivery order transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The contract will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a $33,334.25 delivery order to AmerisourceBergen Drug Corp for the supply of Everolimus 1 mg tablets (60-count units) under a firm fixed price contract. The delivery order was issued on December 17, 2025, with an ultimate completion date of December 18, 2025, and the work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This non-competitive award represents a continuation of the government's pharmaceutical procurement through...
- The Defense Logistics Agency awarded a $3,978.63 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 31, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count) under a firm fixed-price contract valued at $10,949.64. This delivery order, which is a child award under AmerisourceBergen's broader contract vehicle, represents a competitive award with no set-aside designation and is scheduled for completion by August 20, 2025. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Everolimus 5 mg tablets in a quantity of 30 units, valued at $5,193.76. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The contract's ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Everolimus 0.75 mg tablets (60-count) with a ceiling value of $6,624.37. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 11, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child order under a larger vehicle and carries no set-aside designation. This...
- The Defense Logistics Agency (DLA) awarded a $17,318.52 delivery order to AmerisourceBergen Drug Corp for Everolimus 1 mg tablets (60 count) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $26,956.89 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Everolimus 0.5 mg, with an ultimate completion date of September 19, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJE6BDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $52,818.78 to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count units) on December 19, 2025, with a completion date of December 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, reflecting a competitively awarded procurement for pharmaceutical products supporting federal medical supply needs. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, specialty pharmaceuticals, and medical supplies to support military healthcare systems, the Defense Health Agency, and other government healthcare programs worldwide. The Everolimus delivery represents a routine pharmaceutical procurement within the company's established relationship as a prime vendor for DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.8k | 12/18/25 |